---
title: UK private healthcare media reputation tracker – 2026 year to date
canonical_url: https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd
type: dataset
publisher: Omniscan
sector: UK Private Healthcare
period: 2026 year to date
coverage_start: '2026-01-01'
coverage_end: '2026-10-31'
date_published: '2026-11-03'
last_updated: '2026-11-03'
organisations: 8
articles_analysed: 1647
mentions: 1070
data_download: https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/data.json
summary: Spire Healthcare had the highest average monthly share of coverage (32.8%)
  among 8 providers in UK earned media from 1 January 2026 to 31 October 2026, ahead
  of Bupa (20.7%) and Vitality (11.8%).
---

# UK private healthcare media reputation tracker: 2026 year to date (1 January 2026–31 October 2026)

> Spire Healthcare had the highest average monthly share of coverage (32.8%) among 8 providers in UK earned media from 1 January 2026 to 31 October 2026, ahead of Bupa (20.7%) and Vitality (11.8%). Vitality had the most favourable net tone (+64). Omniscan analysed 1,647 articles containing 1,070 mentions of the providers tracked.

Interactive version: https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd

## UK Private Healthcare ranking by share of coverage, 2026 year to date

| Rank | Organisation | Average monthly share of coverage | Mentions | Positive | Neutral | Negative | Net tone |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | Spire Healthcare | 32.8% | 370 | 29% | 53% | 18% | +10 |
| 2 | Bupa | 20.7% | 217 | 62% | 32% | 6% | +56 |
| 3 | Vitality | 11.8% | 120 | 67% | 31% | 2% | +64 |
| 4 | Nuffield Health | 10.9% | 111 | 50% | 31% | 19% | +32 |
| 5 | AXA Health | 8.7% | 87 | 42% | 53% | 5% | +38 |
| 6 | HCA UK | 6.6% | 72 | 43% | 39% | 18% | +25 |
| 7 | Circle Health | 4.5% | 49 | 63% | 16% | 21% | +43 |
| 8 | Ramsay UK | 4.0% | 44 | 41% | 50% | 9% | +32 |

## Monthly share of coverage, UK Private Healthcare

| Organisation | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Spire Healthcare | 43.1% | 32.1% | 43.2% | 15.5% | 38.8% | 23.0% | 29.4% | 36.7% | 42.7% | 23.5% |
| Bupa | 22.5% | 12.8% | 17.8% | 24.1% | 23.3% | 21.6% | 24.7% | 21.5% | 17.5% | 20.8% |
| Vitality | 7.8% | 17.9% | 11.0% | 17.2% | 11.2% | 12.2% | 8.2% | 11.4% | 10.4% | 10.1% |
| Nuffield Health | 9.8% | 20.5% | 6.8% | 15.5% | 3.4% | 5.4% | 14.1% | 10.1% | 7.6% | 16.1% |
| AXA Health | 5.9% | 2.6% | 6.8% | 13.8% | 10.3% | 10.8% | 10.6% | 10.1% | 3.8% | 12.1% |
| HCA UK | 2.9% | 5.1% | 4.2% | 3.4% | 8.6% | 20.3% | 3.5% | 1.3% | 6.6% | 10.1% |
| Circle Health | 2.0% | 5.1% | 6.8% | 8.6% | 2.6% | 5.4% | 3.5% | 1.3% | 6.6% | 3.4% |
| Ramsay UK | 5.9% | 3.8% | 3.4% | 1.7% | 1.7% | 1.4% | 5.9% | 7.6% | 4.7% | 4.0% |

## Providers in detail

### Spire Healthcare

**Takeover saga defined Spire’s benchmark-leading media profile**

Spire Healthcare ranked 1st of 8 by average monthly share of coverage (32.8%) in the UK Private Healthcare benchmark for 2026 year to date, with 370 mentions and a net tone of +10.

Spire Healthcare led the provider benchmark across January to October, with 370 mentions, a 34.6% pooled share of tracked-company mentions and a 32.8% average monthly share, ranking first on both measures. Its higher pooled share reflects particularly strong visibility in high-volume months, notably September, rather than uniform dominance throughout the window. Ownership news formed the central editorial thread, beginning with talks involving Bridgepoint and Triton, continuing through their withdrawal and Toscafund’s approach, and culminating in an agreed £1.03bn take-private transaction. Alongside that corporate story, reporting examined Spire’s operating position, including revenue growth, cost savings, lower NHS commissioning and stronger private-patient channels. Quality and safety coverage was also substantial, led by the Spire Washington patient recall and investigation, historical Ian Paterson cases and individual negligence allegations. A broader service agenda emerged through the Kingston clinic opening, workplace-health launch, genetic-risk testing and AI-enabled MRI deployment. The four-year Bupa partnership, Perth outpatient development and NHS elective surgical hub accreditation extended the profile into insurer relationships, estate expansion and NHS collaboration. Competitive visibility was most exposed in April, when share fell to 15.5% and Spire ranked joint third with Nuffield Health; the month’s stories were dispersed across innovation, partnership, safety and strategy. Spire returned to first place in May as the Toscafund approach brought ownership back to the centre of reporting, and it remained first through October. September was the fullest expression of this profile: the agreed takeover and leadership changes coincided with half-year results showing private-channel growth partly offsetting lower NHS activity.

Key messages:

- Spire Healthcare accounted for 34.6% of tracked-company mentions; its monthly rank ranged from first to joint third among eight providers.
- Coverage concentrated on Financial Results & Ownership and Quality, Safety & CQC.
- Monthly share peaked in March 2026 at 43.2%, compared with 15.5% in April 2026.
- January 2026: Spire entered talks with Bridgepoint and Triton over a possible £1.5bn sale, reported by The Times.

Leading themes:

- Financial Results & Ownership: 75.9% of Spire Healthcare's coverage (theme index 10.22, net tone +16)
- Quality, Safety & CQC: 8.9% of Spire Healthcare's coverage (theme index 1.27, net tone −82)
- Leadership & Strategy: 3.8% of Spire Healthcare's coverage (theme index 0.35, net tone +36)

Notable positive coverage:

- 26 January 2026, proactiveinvestors.com: [Spire Healthcare attracts credible PE interest and sparks valuation debate | LSE:SPI](https://www.proactiveinvestors.com/companies/news/1086238/spire-healthcare-attracts-credible-pe-interest-and-sparks-valuation-debate-1086238.html). Spire Healthcare's preliminary talks with Bridgepoint and Triton prompted analysts to reassess its valuation and the prospects of a bid. Analysts cited the value of its operations and real estate, while noting short-term NHS commissioning constraints.
- 26 January 2026, proactiveinvestors.co.uk: [Spire Healthcare jumps after revealing talks with private equity firms](https://www.proactiveinvestors.co.uk/companies/news/1086226/spire-healthcare-jumps-after-revealing-talks-with-private-equity-firms-1086226.html). Spire Healthcare shares rose after it confirmed preliminary talks with Bridgepoint and Triton as part of its strategic review. The company is considering ways to realise value from its business and property estate.
- 20 March 2026, sharecast.com: [Spire Healthcare surges on report of £1bn Bridgepoint offer](https://www.sharecast.com/news/news-and-announcements/spire-healthcare-surges-on-report-of-pound1bn-bridgepoint-offer--22112960.html). Spire Healthcare shares rose after reports that Bridgepoint was considering a roughly £1bn, 230p-per-share offer. Bridgepoint's interest was described as serious, although a formal bid remained uncertain.

Notable negative coverage:

- 23 March 2026, proactiveinvestors.co.uk: [Spire Healthcare sinks as Bridgepoint and Triton talks terminated](https://www.proactiveinvestors.co.uk/companies/news/1089302/spire-healthcare-sinks-as-bridgepoint-and-triton-talks-terminated-1089302.html). Spire Healthcare shares dropped 18% after takeover discussions with Bridgepoint and Triton were terminated. The operator, which runs nearly 40 hospitals and more than 50 clinics in the UK, is still discussing a potential sale with other parties.
- 30 September 2026, laingbuissonnews.com: [Spire profits hit by declining NHS revenue](https://www.laingbuissonnews.com/healthcare-markets-content/spire-profits-hit-by-declining-nhs-revenue/). Spire Healthcare reported that declining NHS revenue reduced first-half 2026 earnings, with hospital-division revenue down 1.6%. The group is also expected to be taken private by a Toscafund-led consortium.
- 23 March 2026, investorschronicle.co.uk: [Spire and PPHE Hotels: Markets live](https://www.investorschronicle.co.uk/live-blog/d2a6f4ee-b20f-477a-8e47-f0b18ad46d16). Spire Healthcare's share price declined after takeover discussions with Triton and Bridgepoint failed to produce an offer. The company remains in discussions with other potential bidders amid a strategic review.

- [Spire Healthcare deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=spirehealthcare&view=deep-dive)
- [Spire Healthcare PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/spirehealthcare.pdf)

### Bupa

**Prevention, partnerships and provision sustained Bupa’s visibility**

Bupa ranked 2nd of 8 by average monthly share of coverage (20.7%) in the UK Private Healthcare benchmark for 2026 year to date, with 217 mentions and a net tone of +56.

From January to October, Bupa recorded 217 mentions and 20.3% of tracked-company mentions, while its 20.7% average monthly share also placed it second. It ranked second in eight of the ten months, dropping to fourth in February before taking first place in April. Monthly share ranged from 12.8% in February to 24.7% in July, while September produced the highest volume, showing that visibility and competitive share did not always move together. Early reporting combined Bupa’s research on barriers to cancer care and GP appointments with Kate Bovell’s appointment to oversee King Edward VII’s Hospital and its integration into the London network. February’s smaller footprint encompassed the Evolve Master Trust, four planned Arista Medical health centres and The Telegraph’s allegation that Bupa refused to fund breast surgery. The agenda then extended into financial performance, minimum-wage underpayments, genomics-led prevention, skin-cancer assessment and the four-year Spire Healthcare partnership. May and June brought a stronger provision and product strand through the Mindplace mental-health centre, the Canary Wharf outpatient and diagnostic centre, the YuLife health cash plan and Cromwell Hospital’s use of new cardiac-ablation technology. July and August combined leadership appointments and value-based cardiac care with first-half results, genetic-risk testing and drill-free dental treatment. September’s 37 mentions represented the period’s highest volume, although its 17.5% share reflected a much larger cohort total; stories included the Wellbeing Index and changes to Bupa’s UK executive team. October’s share recovered to 20.8% as reporting ranged from personalised cancer support and the Viva Benefits platform to improved activity and narrower losses at Cromwell Hospital.

Key messages:

- Bupa accounted for 20.3% of tracked-company mentions; among eight providers, it ranked first once, second eight times and fourth once.
- Coverage concentrated on Insurance & Self-Pay Demand and Leadership & Strategy.
- Bupa’s monthly share peaked at 24.7% in July 2026, compared with its period low of 12.8% in February 2026.
- January 2026: Personnel Today reported Bupa research showing that many men feared a cancer diagnosis could damage their careers and delay care.

Leading themes:

- Insurance & Self-Pay Demand: 36.9% of Bupa's coverage (theme index 1.95, net tone +56)
- Leadership & Strategy: 15.2% of Bupa's coverage (theme index 2.32, net tone +73)
- Digital Health & Innovation: 14.7% of Bupa's coverage (theme index 1.7, net tone +88)

Notable positive coverage:

- 13 February 2026, healthcareandprotection.com: [Third of men would not tell partner if they had cancer - Bupa](https://healthcareandprotection.com/third-of-men-would-not-tell-partner-if-they-had-cancer-bupa/). Bupa research finds that many men would not discuss cancer symptoms, diagnoses or hereditary risks with their partners. Bupa UK Insurance's medical director urges earlier conversations and symptom checks to support detection.
- 27 February 2026, healthcareandprotection.com: [Bupa launches Evolve Master Trust based on care pathways](https://healthcareandprotection.com/bupa-launches-evolve-master-trust-based-on-care-pathways/). Bupa UK Insurance has launched Bupa Evolve Master Trust for employers with more than 300 staff. The self-funded healthcare product combines Connected Care pathways with stop-loss protection and access to Bupa services and clinical partners.
- 27 February 2026, corporate-adviser.com: [Bupa launches health master trust for larger employers](https://corporate-adviser.com/bupa-launches-health-master-trust-for-larger-employers/). Bupa has introduced its Evolve Master Trust, enabling larger employers to self-fund employee healthcare with stop-loss insurance. The proposition uses Bupa Connected Care pathways, clinics, hospitals and digital services to manage access and costs.

Notable negative coverage:

- 20 March 2026, bbc.com: [North West firms apologise for paying illegally low salaries](https://www.bbc.com/news/articles/crr1l0zw9exo). Bupa Care Services was among employers named by the government for historic minimum-wage underpayments totalling £441,439 across 8,810 workers. The article reports wider enforcement action against nearly 400 employers.
- 13 February 2026, telegraph.co.uk: [‘My wife found a lump in her breast but Bupa refused to pay for surgery’](https://www.telegraph.co.uk/money/consumer-affairs/bupa-refused-to-pay-for-lump-in-breast-surgery/). The article alleges that Bupa refused to fund surgery after a woman found a breast lump.

- [Bupa deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=bupa&view=deep-dive)
- [Bupa PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/bupa.pdf)

### Vitality

**Care expansion and workplace research framed Vitality’s uneven visibility**

Vitality ranked 3rd of 8 by average monthly share of coverage (11.8%) in the UK Private Healthcare benchmark for 2026 year to date, with 120 mentions and a net tone of +64.

Vitality recorded 120 mentions and ranked third across the ten-month window, with 11.2% of tracked-company mentions. Its average monthly share was slightly higher at 11.8%, also placing it third, because each month received equal weight rather than larger months dominating the result. Vitality opened in fourth place on 7.8% in January before rising to third on 17.9% in February. April delivered its best competitive position, second place on 17.2%, despite a lower volume than in March. From May, its position softened from third to fourth in June and fifth in July, when share fell to 8.2%. August and September brought a return to third place, although September’s substantial volume increase occurred amid much greater activity across the tracked cohort. October ended the period with Vitality joint fifth with HCA UK on 10.1%, only 0.3 percentage points below September but two places lower. Early coverage ranged from a return to profit and senior appointments to sleep research and the HealthHero virtual-GP partnership. The Boots weight-management partnership, faster underwriting, children’s mental-health pathway and one-million-insured-lives milestone broadened the middle of the period. Later reporting combined stronger financial results, cancer navigation, workforce-health research and expanded primary-care access, giving Vitality a profile spanning protection, prevention, service delivery and corporate strategy.

Key messages:

- Vitality accounted for 11.2% of tracked-company mentions; its monthly rank ranged from second to fifth among eight companies, including joint fifth in October.
- Coverage concentrated on Insurance & Self-Pay Demand and Leadership & Strategy.
- Monthly share peaked in February 2026 at 17.9%, compared with 7.8% in January 2026.
- January 2026: City A.M. reported Vitality’s return to profit as insurance revenue passed £1bn.

Leading themes:

- Insurance & Self-Pay Demand: 70.8% of Vitality's coverage (theme index 4.31, net tone +54)
- Leadership & Strategy: 10.8% of Vitality's coverage (theme index 1.35, net tone +92)
- Digital Health & Innovation: 10.0% of Vitality's coverage (theme index 1.01, net tone +92)

Notable positive coverage:

- 12 March 2026, ifamagazine.com: [Insurer Vitality launches industry first healthcare partnership with Boots](https://ifamagazine.com/insurer-vitality-launches-industry-first-healthcare-partnership-with-boots/). Vitality has partnered with Boots to offer members discounted access to Boots Online Doctor's weight-loss service from spring. The partnership is intended to expand into further health and wellbeing services.
- 13 March 2026, thepharmacist.co.uk: [Vitality Insurance partners with Boots to offer discounted weight loss jabs and services](https://www.thepharmacist.co.uk/community/vitality-insurance-partners-with-boots-to-offer-discounted-weight-loss-jabs-and-services/). Vitality has partnered with Boots to offer members discounted access to weight-loss medication and clinical support, with larger discounts linked to higher Vitality activity status. The insurer said the initiative supports prevention and healthier behaviours alongside GLP-1 treatment.
- 16 March 2026, insurancebusinessmag.com: [Vitality partners with Boots to expand GLP‑1 weight loss access for members](https://www.insurancebusinessmag.com/uk/news/breaking-news/vitality-partners-with-boots-to-expand-glp1-weight-loss-access-for-members-568593.aspx). Vitality has partnered with Boots to offer eligible health-insurance members discounted access to Boots Online Doctor's weight-loss service, including clinically appropriate GLP-1 treatments. The partnership may later expand into further primary-care and wellbeing services.

Notable negative coverage:

- 19 January 2026, inews.co.uk: [I lost my wife to cancer - private health insurance just made a hard time worse](https://inews.co.uk/inews-lifestyle/wife-cancer-private-health-insurance-hard-time-worse-4112924). A bereaved husband says Vitality declined to fund several advanced or unlicensed glioblastoma treatments under his employer-funded policy, leaving the family to self-fund or crowdfund. Vitality said it funded all eligible claims but does not cover experimental, unlicensed or insufficiently proven treatments.

- [Vitality deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=vitality&view=deep-dive)
- [Vitality PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/vitality.pdf)

### Nuffield Health

**Visibility recovered amid broader technology, services and community coverage**

Nuffield Health ranked 4th of 8 by average monthly share of coverage (10.9%) in the UK Private Healthcare benchmark for 2026 year to date, with 111 mentions and a net tone of +32.

Across ten months, Nuffield Health recorded 111 mentions and ranked fourth on both its 10.4% pooled share and 10.9% average monthly share of tracked-company mentions. January placed it third, with reporting spanning National Joint Registry Gold ratings, the MyStaff rollout, a new cardioversion service and Alex Perry’s case for using independent-sector capacity to reduce NHS backlogs. Its highest share was 20.5% in February, when it ranked second alongside news of the £200 million imaging programme’s Oxford hub, new governors, infection-prevention accreditation and approval for a Derby cancer centre. March brought a fall to 6.8% and joint fourth place as coverage centred more narrowly on clinical advice, the AFC Bournemouth partnership and the Holly Hospital inquest. The March evidence also included contextual references in sector-wide reporting on women’s representation among private-hospital surgeons; these were not Nuffield Health developments. April recovered to 15.5% and joint third place amid reporting on consultant restrictions, the Bethan Littlewood tribunal and Aquablation treatment, before repeated tribunal stories dominated May’s four mentions and sixth-place position. June was joint sixth, although the available stories broadened to a new biologic therapy, a local sports partnership and prostate-screening guidance. July returned Nuffield Health to third place on 14.1%, with reporting on its financial results, Histolog adoption and national operating-theatre accreditation programme. August brought a joint fourth-place finish, while September placed it fourth; the two months combined further technology, estate and research developments—including Wattbike testing, the Wellcome Genome Campus proposal and the 10,000-participant prostate-cancer study—with operational and regulatory reporting. October closed the period at 16.1% and third place. Stories included robotic surgery, NHS-linked cancer exercise, community rehabilitation, theatre accreditation and clinical expertise.

Key messages:

- Nuffield Health accounted for 10.4% of tracked-company mentions; its monthly rank ranged from second to sixth among eight companies.
- Coverage concentrated on Other and Hospitals, Clinics & Estate.
- Monthly share peaked in February 2026 at 20.5%, compared with 3.4% in May 2026.
- January 2026: National Joint Registry Gold ratings across all 33 eligible hospitals and the MyStaff rollout featured in Healthcare Today.

Leading themes:

- Other: 18.9% of Nuffield Health's coverage (theme index 3.3, net tone +19)
- Hospitals, Clinics & Estate: 17.1% of Nuffield Health's coverage (theme index 2.83, net tone +68)
- Digital Health & Innovation: 16.2% of Nuffield Health's coverage (theme index 1.77, net tone +89)

Notable positive coverage:

- 31 July 2026, ifamagazine.com: [Nuffield Health leads independent sector with UK-first adoption of Histolog® real-time cancer assessment technology during prostate surgery](https://ifamagazine.com/nuffield-health-leads-independent-sector/). Nuffield Health Parkside Hospital has introduced the Histolog real-time tissue-assessment scanner for robotic prostatectomy procedures. The provider says it is the first independent hospital operator to adopt the technology.
- 10 September 2026, laingbuissonnews.com: [Nuffield Health and Prostate Cancer Research launch 10,000-patient screening study](https://www.laingbuissonnews.com/healthcare-markets-content/nuffield-health-and-prostate-cancer-research-launch-10000-patient-screening-study/). Nuffield Health and Prostate Cancer Research have launched the BEYOND-PSA study, involving up to 10,000 men, to assess the Stockholm3 blood test in a UK clinical pathway. The study examines earlier detection of clinically significant prostate cancer.
- 29 October 2026, scotsman.com: [Discover why Edinburgh hospital is investing in AI smart scans to help patient care](https://www.scotsman.com/sponsored/nuffield-health-edinburgh-ai-mri-ct-dexa-scanners-9313619). Nuffield Health Edinburgh Hospital has invested in AI-assisted MRI, CT and DEXA imaging equipment in partnership with GE. The hospital says the technology will improve scan quality, efficiency, diagnostic confidence and patient comfort.

Notable negative coverage:

- 31 May 2026, bbc.com: [Bridgend Nuffield employee wins £149,000 at employment tribunal](https://www.bbc.com/news/articles/clyp0qz0d14o). A former Nuffield Health personal trainer won about £149,000 after an employment tribunal upheld claims including wage and holiday-pay deductions, unfair dismissal and poor treatment. Nuffield Health said it was disappointed with the decision and could not comment further while an appeal process continued.
- 26 May 2026, independent.co.uk: [Athlete wins £150k payout after driving from Germany for meeting her boss skipped](https://www.independent.co.uk/news/uk/home-news/bethan-littlewood-nuffield-health-b2983516.html). An employment tribunal awarded former Nuffield Health personal trainer Bethan Littlewood nearly £150,000 after finding she had been subjected to unreasonable treatment, withheld pay and constructive dismissal. The tribunal criticised Nuffield Health's handling of her leave request, disciplinary process and complaints.
- 22 April 2026, personneltoday.com: [Personal trainer who raised concerns wins £150k at tribunal](https://www.personneltoday.com/hr/personal-trainer-tribunal-nuffield-health-littlewood/). An employment tribunal found that Nuffield Health constructively and unfairly dismissed a Cardiff personal trainer after she raised a safety concern about an MoD fitness test. The company was ordered to pay almost £150,000 in compensation, tax and statutory payments.

- [Nuffield Health deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=nuffieldhealth&view=deep-dive)
- [Nuffield Health PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/nuffieldhealth.pdf)

### AXA Health

**AXA Health broadens care agenda amid uneven visibility**

AXA Health ranked 5th of 8 by average monthly share of coverage (8.7%) in the UK Private Healthcare benchmark for 2026 year to date, with 87 mentions and a net tone of +38.

AXA Health recorded 87 mentions and an 8.1% pooled share of tracked-company mentions between January and October, ranking fifth on both pooled share and its 8.7% average monthly share. Visibility was uneven: it ranked eighth in February and September, joint fourth in March and August, and fourth outright in May, July and October. January established a varied agenda through Dr Corné Hurter’s appointment, a small-business insurance discount and research on workforce resilience. February’s reduced presence centred on The Times reporting that AXA Health had declined to fund the Optune cancer treatment. March and April broadened coverage through Cover That Cares research on disclosing health concerns, clinical guidance on breast-cancer symptoms and research into the risks of AI symptom-checking. May produced the highest volume before October, combining research into pressures on sandwich-generation carers with AXA Health’s case for healthcare trusts and sponsored Guardian material about member support. June and July brought greater emphasis on expert and workplace commentary, including digital health twins, extreme-heat risks, connected mental-health services and the Mind Health Report. August added tangible service and leadership news through new online cardiology, neurology and urology pathways and two appointments. September retained eight mentions but fell to eighth place as tracked-company coverage across the cohort expanded, while AXA Health published research on young workers’ ability to recognise deteriorating mental health. October closed the window with 18 mentions and fourth place, alongside expanded Peppy services, Cover That Cares research on how generations express care and reporting on barriers to professional mental-health support.

Key messages:

- AXA Health accounted for 8.1% of tracked-company mentions; it ranked between fourth and eighth among eight companies, including joint fourth place in March and August.
- Coverage concentrated on Insurance & Self-Pay Demand and Leadership & Strategy.
- Monthly share peaked in April 2026 at 13.8%, compared with 2.6% in February 2026.
- January 2026: Healthcare & Protection reported AXA Health’s appointment of Dr Corné Hurter as medical director for services and delivery.

Leading themes:

- Insurance & Self-Pay Demand: 72.4% of AXA Health's coverage (theme index 4, net tone +32)
- Leadership & Strategy: 11.5% of AXA Health's coverage (theme index 1.43, net tone +80)
- Digital Health & Innovation: 8.0% of AXA Health's coverage (theme index 0.8, net tone +43)

Notable positive coverage:

- 19 May 2026, theguardian.com: [‘My role is to stay calm’: how the AXA Health teams support members at their toughest moments](https://www.theguardian.com/stories-of-care/2026/may/19/how-axa-health-teams-support-members-in-tough-moments). Sponsored content profiles AXA Health claims and mental-health case-management staff supporting members through treatment access and complex claims.
- 2 October 2026, corporate-adviser.com: [AXA Health reveals technology overhauling approaches to care](https://corporate-adviser.com/axa-health-reveals-technology-overhauling-approaches-to-care/). AXA Health commissioned research on how different generations use technology to express care as part of its Cover that Cares campaign. CEO Heather Smith said the findings highlighted the value of staying connected for mental and emotional wellbeing.
- 8 October 2026, healthcareandprotection.com: [Axa Health rolls out additional men's and women's testing and treatment options with Peppy](https://healthcareandprotection.com/axa-health-rolls-out-additional-mens-and-womens-testing-and-treatment-options-with-peppy/). AXA Health has expanded its Peppy-delivered workplace health services with additional testing, treatment options and clinically appropriate private prescriptions. The additions cover men's and women's health, fertility, pregnancy, early parenthood and menopause support.

Notable negative coverage:

- 18 February 2026, thetimes.com: ['My health cover left me paying £20k a month to stay alive'](https://www.thetimes.com/money/family-finances/article/my-health-cover-left-me-paying-20k-a-month-to-stay-alive-c2fbr2qbd). Patients with glioblastoma say AXA Health and Vitality declined to fund Optune, a costly wearable cancer treatment, leaving them to self-fund. The article contrasts their policies with Bupa and other insurers that reportedly cover the treatment.
- 20 April 2026, scottishlegal.com: [Employee dismissed on health grounds can amend claim to pursue Permanent Health Insurance Payments past termination date](https://www.scottishlegal.com/articles/employee-dismissed-on-health-grounds-can-amend-claim-to-pursue-permanent-health-insurance-payments-past-termination-date). A Court of Session appeal found AXA Health Services could have a continuing obligation to pay an employee's contractual permanent health insurance benefits after dismissal for incapacity. The case was remitted to the Employment Tribunal to determine eligibility and payment amounts.

- [AXA Health deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=axahealth&view=deep-dive)
- [AXA Health PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/axahealth.pdf)

### HCA UK

**Investment, innovation and scrutiny defined HCA UK’s January-to-October period**

HCA UK ranked 6th of 8 by average monthly share of coverage (6.6%) in the UK Private Healthcare benchmark for 2026 year to date, with 72 mentions and a net tone of +25.

Across January to October, HCA UK recorded 72 mentions, representing a 6.7% pooled share of tracked-company mentions and an average monthly share of 6.6%, ranking sixth on both measures. The period opened with HCA UK seventh in January on 2.9%; the available articles were contextual references concerning the Yaser Jabbar review and an AXA Health appointment rather than developments at HCA UK. February brought a move to joint fifth and coverage of the £17m St Paul’s Outpatients investment in the City of London. March and April combined clinical innovation with expert commentary, including Histotripsy at The Wellington Hospital, sleep advice, renal denervation at The Harborne Hospital and HCA UK’s claims for earlier breast-cancer diagnosis. HCA UK returned to fifth in May on 8.6%, when stories included the Canary Wharf fertility clinic, cancer-diagnostics commentary and specialist care at Christie Private Care. Its strongest competitive position came in June, when a 20.3% share placed it third amid reporting on melanoma treatment, Wellington Hospital care and The Portland Hospital’s maternity services. Share then fell to 3.5% and joint seventh in July and 1.3% and joint seventh in August, although coverage included sustainability initiatives and the expansion of CAR T-cell therapy to Christie Private Care. September recovered to 6.6% and joint fifth, alongside extensive reporting on the Lady Joan Branson inquest and HCA UK’s £15m MR-guided radiotherapy investment. October increased to 10.1% while HCA UK remained joint fifth, with the agenda broadening through clinical explainers and the rollout of exercise-free cardiorespiratory fitness testing. Overall, visibility varied widely across a profile spanning capital investment, advanced cancer care, patient stories, clinical scrutiny and expert-led public-health coverage.

Key messages:

- HCA UK accounted for 6.7% of tracked-company mentions; its monthly position ranged from third to seventh among eight companies, with joint rankings in February, July, August, September and October.
- Coverage concentrated on Hospitals, Clinics & Estate and Quality, Safety & CQC.
- Monthly share peaked in June 2026 at 20.3%, compared with 1.3% in August 2026.
- February 2026: HCA UK’s £17m St Paul’s Outpatients investment, reported by LaingBuisson News.

Leading themes:

- Hospitals, Clinics & Estate: 27.8% of HCA UK's coverage (theme index 4.86, net tone +70)
- Quality, Safety & CQC: 25.0% of HCA UK's coverage (theme index 3.9, net tone −50)
- Digital Health & Innovation: 19.4% of HCA UK's coverage (theme index 2.11, net tone +86)

Notable positive coverage:

- 17 February 2026, laingbuissonnews.com: [HCA Healthcare UK to invest £17m in new City of London outpatients centre](https://www.laingbuissonnews.com/healthcare-markets-content/hca-healthcare-uk-to-invest-17m-in-new-city-of-london-outpatients-centre/). HCA Healthcare UK will invest £17m in St Paul's Outpatients, an outpatient, primary-care and diagnostics centre at Paternoster Square in the City of London. The centre is scheduled to open in early 2027.
- 6 May 2026, buildingbetterhealthcare.com: [HCA Healthcare UK opens fertility satellite clinic at Canary Wharf](https://buildingbetterhealthcare.com/hca-healthcare-uk-opens-fertility-satellite-clinic-at). HCA Healthcare UK has opened a fertility satellite clinic at its Canary Wharf Outpatients Centre. The clinic provides consultations, scans and blood testing, with procedures referred to the Lister Fertility Clinic in Chelsea.
- 6 October 2026, cityam.com: [How to choose your private hospital](https://www.cityam.com/how-to-choose-your-private-hospital/). HCA Healthcare UK provides guidance for patients choosing a private hospital, covering specialist expertise, CQC ratings, complex-care capability and consultant support. It highlights HCA UK hospitals including London Bridge Hospital and The Portland Hospital.

Notable negative coverage:

- 9 September 2026, independent.co.uk: [Hospital's failures contributed to death of Richard Branson's wife, inquest finds](https://www.independent.co.uk/news/uk/home-news/richard-branson-wife-death-joan-templeman-inquest-hospital-medication-b3047507.html). An inquest found that failures to provide anticoagulation and promptly assess VTE risk at HCA UK's Lister Hospital contributed to Lady Joan Branson's death. The hospital said it had undertaken work to strengthen VTE and risk-prevention procedures.
- 9 September 2026, mirror.co.uk: [Richard Branson's wife died after hospital failed to provide proper medication](https://www.mirror.co.uk/3am/celebrity-news/richard-branson-wife-joan-inquest-37642152). An inquest found that the failure to provide prophylactic anticoagulation at HCA UK's Lister Hospital contributed to Lady Joan Branson's death from pulmonary embolism. The coroner said her death would likely have been prevented with the medication.
- 9 September 2026, bbc.co.uk: [Death of Sir Richard Branson's wife linked to lack of preventative medication](https://www.bbc.co.uk/news/articles/c5y7k9n7exyo). An inquest found that failure to provide preventative anticoagulation at HCA UK's Lister Hospital contributed to Lady Joan Branson's death from a pulmonary embolism. The coroner said the death was likely preventable but did not amount to neglect.

- [HCA UK deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=hcauk&view=deep-dive)
- [HCA UK PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/hcauk.pdf)

### Circle Health

**Laboratory expansion accompanied Circle Health’s September volume high**

Circle Health ranked 7th of 8 by average monthly share of coverage (4.5%) in the UK Private Healthcare benchmark for 2026 year to date, with 49 mentions and a net tone of +43.

Circle Health recorded 49 mentions, representing 4.6% of tracked-company mentions from January to October, and ranked seventh by both pooled and average monthly share. Its monthly position improved from eighth in January to joint fourth in March as volume rose from two to eight and share reached 6.8%. Stories during this period included Mehdi Erfan’s appointment as general counsel, Beardwood Hospital retaining a good CQC rating and Clementine Churchill Hospital installing the da Vinci 5 surgical system. April produced the period’s highest share, at 8.6%, while volume fell to five and the monthly rank moved to sixth; reporting included the Huddersfield Town Women partnership and Circle’s response concerning former Fernbrae Hospital patients. Share was 2.6% in May and 5.4% in June, when articles covered the expanded Healix skin-cancer pathway and a dedicated cancer centre at Clementine Churchill Hospital. July and August centred on a disputed breast assessment and Hampshire Clinic’s new children’s outpatient service, with share reaching 1.3% in August. September brought the period’s highest volume, rising from one to 14, while share increased to 6.6% and rank improved from joint seventh to joint fifth. Reporting that month included Circle’s acquisition of selected Unilabs UK laboratory operations, the Lincoln hospital refurbishment and a sponsored account of self-pay activity at Woodlands Hospital. October volume fell to five, share was 3.4% and the monthly rank moved to eighth, while coverage spanned governance technology, clinical expertise, workforce management, screening and ownership. Across the window, Circle’s best monthly rank was joint fourth in March, its highest share came in April and its greatest volume in September, underlining the variation between measures of competitive position.

Key messages:

- Circle Health accounted for 4.6% of tracked-company mentions; its monthly rank ranged from joint fourth to eighth among eight companies.
- Coverage concentrated on Hospitals, Clinics & Estate and Digital Health & Innovation.
- Monthly share peaked in April 2026 at 8.6%, compared with 1.3% in August 2026.
- January 2026: Mehdi Erfan rejoined Circle Health Group as general counsel, reported by LaingBuisson News.

Leading themes:

- Hospitals, Clinics & Estate: 20.4% of Circle Health's coverage (theme index 3.11, net tone +100)
- Quality, Safety & CQC: 18.4% of Circle Health's coverage (theme index 2.57, net tone −22)
- Digital Health & Innovation: 18.4% of Circle Health's coverage (theme index 1.93, net tone +89)

Notable positive coverage:

- 23 June 2026, laingbuissonnews.com: [Circle Health Group develops dedicated cancer centre at Clementine Churchill](https://www.laingbuissonnews.com/healthcare-markets-content/circle-health-group-develops-dedicated-cancer-centre-at-clementine-churchill/). Circle Health Group is developing a dedicated cancer centre at the 98-bed Clementine Churchill Hospital in Harrow. The project forms part of a multi-year investment programme to expand specialist oncology access.
- 14 September 2026, healthcareandprotection.com: [Circle Health takes over selected Unilabs UK laboratory operations](https://healthcareandprotection.com/circle-health-takes-over-selected-unilabs-uk-laboratory-operations/). Circle Health has acquired selected Unilabs UK laboratory operations, adding pathology and diagnostic services serving more than 90 external clients. The group says the integration will improve diagnostic capacity, turnaround times and connectivity across its UK hospital network.
- 23 September 2026, eastmidlandsbusinesslink.co.uk: [APSS commences refurbishment project at Lincoln Private Hospital for Circle Health Group](https://www.eastmidlandsbusinesslink.co.uk/mag/featured/apss-commences-refurbishment-project-at-lincoln-private-hospital-for-circle-health-group/). APSS has begun refurbishing the reception area at Circle Health Lincoln, formerly Lincoln Private Hospital. The project aims to improve the space's functionality and patient and visitor experience while maintaining hospital operations.

Notable negative coverage:

- 15 July 2026, cambridge-news.co.uk: [Mum's ultra-rare illness dismissed by docs as milk cyst](https://www.cambridge-news.co.uk/news/health/st-helens-mums-ultra-rare-34292446). A patient says Circle Health Group's private consultation and scan reassured her that a breast lump was not cancer, before she was later diagnosed with a rare aggressive cancer. Circle Health Group was contacted for comment.
- 15 July 2026, mirror.co.uk: ['My illness was so rare docs dismissed it - I knew something was wrong'](https://www.mirror.co.uk/news/health/docs-dismissed-symptoms-milk-cyst-37432903). A patient reports that Circle Health Group reassured her that a breast lump was not cancer during a private appointment, before subsequent NHS investigations led to a cancer diagnosis. Circle Health Group was contacted for comment.
- 4 April 2026, dailyrecord.co.uk: [Ex-Dundee United captain butchered by disgraced doc blasts Scot Gov](https://www.dailyrecord.co.uk/news/scottish-news/ex-dundee-united-captain-butchered-36967601). Former footballer Iain Jenkins says Circle Health Group has not provided sufficient assurances to private patients harmed by surgeon Sam Eljamel at the former BMI Fernbrae Hospital. Circle says it is supporting affected patients and is seeking clarity from Eljamel's insurer on limitation periods for claims.

- [Circle Health deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=circlehealth&view=deep-dive)
- [Circle Health PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/circlehealth.pdf)

### Ramsay UK

**Ramsay UK coverage broadens beyond earnings in the second half**

Ramsay UK ranked 8th of 8 by average monthly share of coverage (4.0%) in the UK Private Healthcare benchmark for 2026 year to date, with 44 mentions and a net tone of +32.

Ramsay UK recorded 44 mentions from January to October, representing 4.1% of tracked-company mentions on a pooled basis and a 4.0% average monthly share, ranking eighth on both measures. Its monthly position ranged from joint fifth in January to eighth between March and June, before improving to sixth in July and August and seventh in September and October. January’s stronger position came entirely from contextual mentions in wider reporting on Spire Healthcare and a former Ramsay executive, rather than developments at Ramsay UK. Company-focused coverage began in February with reports of improved first-half earnings, alongside continuing UK funding and tariff pressures. April’s sole article concerned the striking-off of a former Woodlands Hospital nurse following findings of misconduct, poor clinical practice and dishonesty. The profile broadened sharply in July as independent news covered the Doctor Care Anywhere virtual-GP pathway, Medneo’s acquisition of the mobile imaging fleet and service contract, and Oaklands Hospital’s Good CQC rating. August combined reporting on improved group earnings and the UK acute-hospital business with a sponsored account of Winfield Hospital’s investment in robotic joint-replacement surgery. September brought the highest volume of the period, with coverage spanning stronger UK earnings, LondonMetric’s sale of two Ramsay-operated hospitals and further sponsored material on Winfield’s robotic surgery. October retained a wider strategic focus through reporting on the proposed Ramsay Santé demerger, while recruitment and the Medneo partnership added workforce and leadership dimensions. Across the period, Ramsay UK’s profile moved from sparse financial and contextual visibility towards a more varied account of digital access, diagnostics, hospital operations and corporate structure.

Key messages:

- Ramsay UK accounted for 4.1% of tracked-company mentions; its monthly rank ranged from joint fifth to eighth among eight companies.
- Coverage concentrated on Financial Results & Ownership and Digital Health & Innovation.
- Monthly share peaked in August 2026 at 7.6%, compared with 1.4% in June 2026.
- February 2026: improved first-half earnings and a higher interim dividend, with UK funding constraints noted, in The Motley Fool Australia.

Leading themes:

- Financial Results & Ownership: 50.0% of Ramsay UK's coverage (theme index 1.65, net tone +23)
- Digital Health & Innovation: 18.2% of Ramsay UK's coverage (theme index 1.9, net tone +88)
- Hospitals, Clinics & Estate: 11.4% of Ramsay UK's coverage (theme index 1.62, net tone +20)

Notable positive coverage:

- 9 July 2026, healthcaretoday.com: [Medneo acquires Ramsay Health Care UK](https://healthcaretoday.com/article/medneo-acquires-ramsay-health-care-uk). Medneo acquired Ramsay Diagnostics UK’s mobile MRI and CT fleet and agreed a six-year exclusive mobile imaging services contract across Ramsay Health Care UK’s hospital network. The transaction also transfers the diagnostic imaging team; it is not an acquisition of Ramsay Health Care UK as a whole.
- 20 July 2026, healthcareandprotection.com: [Doctor Care Anywhere and Ramsay Health Care UK to deliver virtual GP and secondary care pathways](https://healthcareandprotection.com/doctor-care-anywhere-and-ramsay-health-care-uk-to-deliver-virtual-gp-and-secondary-care-pathways/). Ramsay Health Care UK has partnered with Doctor Care Anywhere to offer self-pay virtual GP consultations with clinically led onward referrals to Ramsay hospitals and specialists. Patients retain the option to use NHS or other private providers following an open referral.
- 28 September 2026, soglos.com: [The Gloucestershire hospital helping joint replacement patients 'get back to the life they were missing' – with robotic assistance](https://www.soglos.com/interview/health-wellbeing/the-gloucestershire-hospital-helping-joint-replacement-patients-get-back-to-the-life-they-were-missing--with-robotic-assistance/27203/). Ramsay Health Care UK's Winfield Hospital in Gloucester is promoting its use of Mako SmartRobotics for personalised joint-replacement surgery. The sponsored feature presents the technology as improving surgical precision and patient care.

Notable negative coverage:

- 15 April 2026, examinerlive.co.uk: ['Rude' nurse struck off after puncturing fluid bag in multiple misconduct counts](https://www.examinerlive.co.uk/news/local-news/rude-yorkshire-nurse-struck-after-33770737). A nurse formerly employed at Ramsay UK's Woodlands Hospital in Darlington was struck off by the NMC following findings of serious misconduct, poor clinical practice and dishonesty. The case also involved unsafe medication administration at a separate care home.
- 26 February 2026, fool.com.au: [Why Ramsay Health Care shares are storming 10% higher](https://www.fool.com.au/2026/02/26/why-ramsay-health-care-shares-are-storming-10-higher/). Ramsay Health Care reported improved group first-half FY26 revenue, profitability and EBIT, prompting a rise in its Australian-listed shares. The article notes that its UK acute hospitals continue to face funding constraints and tariff pressure.

- [Ramsay UK deep dive](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd?entity=ramsayuk&view=deep-dive)
- [Ramsay UK PDF report](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd/reports/ramsayuk.pdf)

## Methodology

- **Share of coverage**: an organisation's mentions divided by all mentions of the organisations tracked in the same sector that month, in UK earned media. It is the central measure of media visibility in Omniscan benchmarks. "Average monthly share" is the mean of the monthly shares across the reporting period.
- **Mention**: one article that covers an organisation, classified as positive, neutral or negative in tone. Articles are deduplicated, and an organisation's own websites and passing sponsorship name-checks are excluded, so only earned media counts.
- **Net tone**: positive mentions minus negative mentions, as a percentage of all mentions (range −100 to +100).
- **Themes**: every article is assigned to one of the sector's editorial themes. A theme index above 1 means the organisation is covered on that theme more than its peers are; below 1 means less.
- **Calculation**: every figure is computed directly from the classified articles; narrative summaries are checked against those figures.
- **Sources**: UK national and international, trade and specialist, regional and local, and aggregator and syndication media coverage, including sponsored and contributed material.

## Other UK Private Healthcare editions

- [UK private healthcare media reputation tracker – H1 2026](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-h1.md)
- [UK private healthcare media reputation tracker – July 2026](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-07.md)
- [UK private healthcare media reputation tracker – August 2026](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-08.md)
- [UK private healthcare media reputation tracker – September 2026](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-09.md)
- [UK private healthcare media reputation tracker – October 2026](https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-10.md)
- [All Omniscan media benchmarks](https://www.omniscan.ai/benchmarks.md)

## How to cite

Omniscan, "UK private healthcare media reputation tracker", 2026 year to date (1 January 2026–31 October 2026), published 3 November 2026. https://www.omniscan.ai/benchmarks/uk-private-healthcare-2026-ytd
